H. Collard
Pulmonary and Respiratory Medicine · 2003–2018
A researcher in the Science corpus: 12 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Pulmonary and Respiratory Medicine — 109 citations into it
- Physiology — 32 citations into it
Whom H. Collard trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from H. Collard's perspective
Ordered by how strongly the researchers H. Collard trusts endorse each paper. Same corpus, a different order for every researcher.
- Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. (Chest)
- Incidence and prevalence of idiopathic pulmonary fibrosis. (American Journal of Respiratory and Critical Care Medicine)
- Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. (American Journal of Respiratory and Critical Care Medicine)
- Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? (American Journal of Respiratory and Critical Care Medicine)
- Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. (The Lancet Respiratory Medicine)
- Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. (The Lancet Respiratory Medicine)
- Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours (Journal of Thoracic Oncology)
- Prognostic Models With Competing Risks: Methods and Application to Coronary Risk Prediction (Epidemiology)
- Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma
Their papers
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline (2018) — 3,214 citations
- Idiopathic pulmonary fibrosis (2017) — 970 citations
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. (2015) — 1,536 citations
- An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features (2015) — 879 citations
- Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. (2014) — 598 citations
- Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. (2014) — 2,107 citations
- An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. (2013) — 3,543 citations
- Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis (2013) — 722 citations
- A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis (2012) — 1,181 citations
- Clinical course and prediction of survival in idiopathic pulmonary fibrosis. (2011) — 1,495 citations
- Clinical and economic consequences of ventilator-associated pneumonia: A systematic review (2005) — 1,084 citations
- Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. (2003) — 744 citations